Display options
Cite
Kim BH, Kim KH, Ko YH, et al. The prostatic urethral angle can predict the response to alpha adrenoceptor antagonist monotherapy for treating nocturia in men with lower urinary tract symptom: A multicenter study. Prostate Int. 2016;4(1):30-5doi: 10.1016/j.prnil.2015.12.002.
Kim, B. H., Kim, K. H., Ko, Y. H., Song, P. H., Kim, T. H., & Kim, B. S. (2016). The prostatic urethral angle can predict the response to alpha adrenoceptor antagonist monotherapy for treating nocturia in men with lower urinary tract symptom: A multicenter study. Prostate international, 4(1), 30-5. https://doi.org/10.1016/j.prnil.2015.12.002
Kim, Byung Hoon, et al. "The prostatic urethral angle can predict the response to alpha adrenoceptor antagonist monotherapy for treating nocturia in men with lower urinary tract symptom: A multicenter study." Prostate international vol. 4,1 (2016): 30-5. doi: https://doi.org/10.1016/j.prnil.2015.12.002
Kim BH, Kim KH, Ko YH, Song PH, Kim TH, Kim BS. The prostatic urethral angle can predict the response to alpha adrenoceptor antagonist monotherapy for treating nocturia in men with lower urinary tract symptom: A multicenter study. Prostate Int. 2016 Mar;4(1):30-5. doi: 10.1016/j.prnil.2015.12.002. Epub 2016 Jan 14. PMID: 27014662; PMCID: PMC4789331.
Copy Download .nbib Format: NLM
Share it on

Prostate Int. 2016 Mar;4(1):30-5. doi: 10.1016/j.prnil.2015.12.002. Epub 2016 Jan 14.

The prostatic urethral angle can predict the response to alpha adrenoceptor antagonist monotherapy for treating nocturia in men with lower urinary tract symptom: A multicenter study.

Prostate international

Byung Hoon Kim, Ki Ho Kim, Young Hwii Ko, Phil Hyun Song, Tae-Hwan Kim, Bum Soo Kim

Affiliations

  1. Department of Urology, Keimyung University School of Medicine, Daegu, South Korea.
  2. Department of Urology, Dongguk University College of Medicine, Gyeongju, South Korea.
  3. Department of Urology, College of Medicine, Yeungnam University, Daegu, South Korea.
  4. Department of Urology, School of Medicine, Kyungpook National University, Daegu, South Korea.

PMID: 27014662 PMCID: PMC4789331 DOI: 10.1016/j.prnil.2015.12.002

Abstract

BACKGROUND: We evaluated ultrasonography variables associated with the improvement of nocturia after administration of alpha adrenoceptor antagonist (alpha blocker) monotherapy.

METHODS: From February to October 2014, 679 men with lower urinary tract symptoms (LUTS) underwent ultrasonography including prostate volume, transitional zone volume, prostatic urethral length, the ratio between prostatic urethral length and prostate volume (RPUL), intravesical prostatic protrusion (IPP), and prostatic urethral angle (PUA). Among them, 108 men who had pre-treatment nocturia without nocturnal polyuria (nocturnal polyuria index < 33%) and were treated with alpha blocker monotherapy over 3 months were enrolled. Patients were divided into the improved (< 2 times of nocturia) and non-improved group (more than 2 times) after administration of alpha blockers. Along with ultrasonography, international prostate symptom score (IPSS) and uroflowmetry was assessed.

RESULTS: After alpha blocker treatment, 25.0% of patients (27/108) showed improvement of nocturia. These patients were significantly younger (59.6 vs 68.0 years, P = < 0.001) with lower PUA (31.8 vs. 39.4°, P = 0.009) compared with the non-improved group. In ROC analysis, the area under the curve using the PUA was 0.653 (95% CI = 0.532-0.774, P = 0.018). Using 33.5° as a cut-off level, the sensitivity and specificity for predicting the improvement of nocturia after medication reached 67.9% and 55.6%, respectively. Patients with lower PUA (PUA < 33.5°) had more improvement of nocturia (36.6 vs. 17.9%, P = 0.030), lower IPSS score (14.2 vs. 18.3, P = 0.005), and better quality of life index (3.1 vs 3.8, P = 0.021).

CONCLUSIONS: In the patients with lower PUA (particularly lower than 33.5°), nocturia was improved by administration of alpha blocker monotherapy.

Keywords: Adrenergic alpha-antagonists; Benign prostatic hyperplasia; Nocturia; Prostate

References

  1. J Urol. 2000 Oct;164(4):1201-5 - PubMed
  2. Neurourol Urodyn. 2002;21(2):179-83 - PubMed
  3. BJU Int. 2002 Dec;90 Suppl 3:11-5 - PubMed
  4. J Urol. 2003 Jul;170(1):145-8 - PubMed
  5. BJU Int. 2003 Aug;92(3):257-61 - PubMed
  6. J Urol. 2003 Dec;170(6 Pt 1):2339-41 - PubMed
  7. BJU Int. 2005 Sep;96 Suppl 1:8-14 - PubMed
  8. Scand J Prim Health Care. 1992 Jun;10(2):98-104 - PubMed
  9. Plant Mol Biol. 1991 Sep;17(3):493-8 - PubMed
  10. Eur Urol. 2006 Apr;49(4):651-8 - PubMed
  11. BJU Int. 2006 Apr;97(4):747-51, discussion 751 - PubMed
  12. BJU Int. 2006 May;97(5):1017-23 - PubMed
  13. Urology. 2006 Jun;67(6):1188-92 - PubMed
  14. Urology. 2006 Sep;68(3):560-4 - PubMed
  15. J Urol. 2006 Dec;176(6 Pt 1):2541-5; discussion 2545 - PubMed
  16. Urology. 2007 Sep;70(3):493-7 - PubMed
  17. Urology. 2007 Dec;70(6):1096-9 - PubMed
  18. Neurourol Urodyn. 2009;28(5):427-31 - PubMed
  19. Urology. 2010 Jun;75(6):1467-71 - PubMed
  20. J Urol. 2010 Aug;184(2):440-6 - PubMed
  21. BJU Int. 2011 Aug;108(3):388-94 - PubMed
  22. Korean J Urol. 2012 Jun;53(6):410-3 - PubMed
  23. Urology. 2012 Dec;80(6):1333-7 - PubMed
  24. Br J Urol. 1990 Aug;66(2):175-6 - PubMed
  25. Korean J Urol. 2013 Aug;54(8):492-8 - PubMed
  26. Curr Opin Urol. 2014 Jan;24(1):21-8 - PubMed
  27. Int Neurourol J. 2014 Jun;18(2):86-90 - PubMed
  28. Drug Des Devel Ther. 2014 Jul 15;8:937-43 - PubMed
  29. Korean J Urol. 2015 Jan;56(1):68-75 - PubMed
  30. Low Urin Tract Symptoms. 2016 May;8(2):113-9 - PubMed
  31. Br J Urol. 1994 Nov;74(5):551-5 - PubMed
  32. Urology. 1997 Oct;50(4):548-55 - PubMed
  33. Neurourol Urodyn. 1998;17(5):467-72 - PubMed

Publication Types